News

UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.

Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.

Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.

Partnership to launch joint precision medicine studies, bring new clinical trial services to market and advance care protocols for alzheimer’s patients.

Exigent announces investment in molecular diagnostic company ImmunArray who are pioneering new and more accurate ways to diagnose autoimmune diseases.

Particle Matrix's ZetaView particle characterisation system used by Cell Guidance Systems for exosome research.

Researchers have manipulated proteins, sourced from tumour cells, that are essential for maintaining tumour cells and in doing so, have significantly reduced the ability of cancer cells.

A new way to control the activity of a protein, that is often upregulated in cancer, has been discovered by Moffitt researchers through monoubiquitination mechanism.

The spin-out company has raised £500K to fund further development towards CE-marking and human study trials.

Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.